Similar articles for PMID: 16841622

Year	Number of Results
1978	1
1981	1
1989	1
1990	1
1994	1
1995	1
1996	2
1997	2
1999	5
2000	3
2001	2
2002	9
2003	7
2004	15
2005	6
2006	21
2007	14
2008	18
2009	25
2010	19
2011	18
2012	18
2013	13
2014	13
2015	8
2016	11
2017	10
2018	17
2019	28
2020	25
2021	28
2022	25
2023	8
2024	2

1

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group. Biederman J, et al. J Clin Psychiatry. 2006 May;67(5):727-35. doi: 10.4088/jcp.v67n0506. J Clin Psychiatry. 2006. PMID: 16841622 Clinical Trial.

2

Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.

Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J. Swanson JM, et al. J Clin Psychiatry. 2006 Jan;67(1):137-47. doi: 10.4088/jcp.v67n0120. J Clin Psychiatry. 2006. PMID: 16426100 Clinical Trial.

3

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.

Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L. Biederman J, et al. Pediatrics. 2005 Dec;116(6):e777-84. doi: 10.1542/peds.2005-0617. Pediatrics. 2005. PMID: 16322134 Clinical Trial.

4

Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.

Biederman J, Pliszka SR. Biederman J, et al. J Pediatr. 2008 Mar;152(3):394-9. doi: 10.1016/j.jpeds.2007.07.052. Epub 2007 Oct 24. J Pediatr. 2008. PMID: 18280848

5

Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.

Boellner SW, Earl CQ, Arora S. Boellner SW, et al. Curr Med Res Opin. 2006 Dec;22(12):2457-65. doi: 10.1185/030079906X148300. Curr Med Res Opin. 2006. PMID: 17257460 Clinical Trial.

6

A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.

Greenhill LL, Biederman J, Boellner SW, Rugino TA, Sangal RB, Earl CQ, Jiang JG, Swanson JM. Greenhill LL, et al. J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):503-511. doi: 10.1097/01.chi.0000205709.63571.c9. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 16601402 Clinical Trial.

7

Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Spencer TJ, et al. Clin Ther. 2006 Feb;28(2):266-79. doi: 10.1016/j.clinthera.2006.02.011. Clin Ther. 2006. PMID: 16678648 Clinical Trial.

8

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S. Kahbazi M, et al. Psychiatry Res. 2009 Aug 15;168(3):234-7. doi: 10.1016/j.psychres.2008.06.024. Epub 2009 May 12. Psychiatry Res. 2009. PMID: 19439364 Clinical Trial.

9

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ. Kelsey DK, et al. Pediatrics. 2004 Jul;114(1):e1-8. doi: 10.1542/peds.114.1.e1. Pediatrics. 2004. PMID: 15231966 Clinical Trial.

10

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Biederman J, et al. Clin Ther. 2007 Mar;29(3):450-63. doi: 10.1016/s0149-2918(07)80083-x. Clin Ther. 2007. PMID: 17577466 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

318 results

Results by year